Suppression of MG132-mediated cell death by peroxiredoxin 1 through influence on ASK1 activation in human thyroid cancer cells

Endocrine-Related Cancer

Volumn 17, Issue 3, 2010, Pages 553-560

  Du, Zhen Xian ^a   Yan, Ying ^b   Zhang, Hai Yan ^a   Liu, Bao Qin ^a   Gao, Yan Yan ^a   Niu, Xiao Fang ^a   Guan, Yifu ^a   Meng, Xin ^a   Wang, Hua Qin ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b SHENYANG NORTHERN HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXIREDOXIN 1; STRESS ACTIVATED PROTEIN KINASE; BENZYLOXYCARBONYLLEUCYL LEUCYL LEUCINE ALDEHYDE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; CYSTEINE PROTEINASE INHIBITOR; LEUPEPTIN; MESSENGER RNA; PEROXIREDOXIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRESS; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; THYROID CANCER; ANALYSIS OF VARIANCE; CELL DEATH; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID GLAND; TUMOR CELL LINE; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CELL DEATH; CELL LINE, TUMOR; CYSTEINE PROTEINASE INHIBITORS; HUMANS; LEUPEPTINS; MAP KINASE KINASE KINASE 5; PEROXIREDOXINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID GLAND; TRANSFECTION;

EID: 77956219444     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0269     Document Type: Article

References (36)

1. Adams J 2004 The proteasome: a suitable antineoplastic target. Nature Reviews. Cancer 4 349-360.
2. Alfonso P, Catala M, Rico-Morales ML, Durante-Rodriguez G, Moro-Rodriguez E, Fernandez-Garcia H, Escribano JM, Alvarez-Fernandez E & Garcia-Poblete E 2004 Proteomic analysis of lung biopsies: differential protein expression profile between peritumoral and tumoral tissue. Proteomics 4 442-447.
3. Butzke D, Machuy N, Thiede B, Hurwitz R, Goedert S & Rudel T 2004 Hydrogen peroxide produced by Aplysia ink toxin kills tumor cells independent of apoptosis via peroxiredoxin I sensitive pathways. Cell Death and Differentiation 11 608-617.
4. Chang HY, Nishitoh H, Yang X, Ichijo H & Baltimore D 1998 Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science 281 1860-1863.
5. Chang JW, Jeon HB, Lee JH, Yoo JS, Chun JS, Kim JH & Yoo YJ 2001 Augmented expression of peroxiredoxin I in lung cancer. Biochemical and Biophysical Research Communications 289 507-512.
6. Egler RA, Fernandes E, Rothermund K, Sereika S, de Souza-Pinto N, Jaruga P, Dizdaroglu M & Prochownik EV 2005 Regulation of reactive oxygen species, DNA damage, and c-Myc function by peroxiredoxin 1. Oncogene 24 8038-8050.
7. Goldman EH, Chen L & Fu H 2004 Activation of apoptosis signal-regulating kinase 1 by reactive oxygen species through dephosphorylation at serine 967 and 14-3-3 dissociation. Journal of Biological Chemistry 279 10442-10449.
8. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K & Gotoh Y 1997 Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275 90-94.
9. Immenschuh S, Iwahara S & Schwennen B 2002 Induction of heme-binding protein 23/peroxiredoxin I gene expression by okadaic acid in cultured rat hepatocytes. DNA and Cell Biology 21 347-354. (Pubitemid 34594547)
10. Ishii T, Itoh K, Akasaka J, Yanagawa T, Takahashi S, Yoshida H, Bannai S & Yamamoto M 2000 Induction of murine intestinal and hepatic peroxiredoxin MSP23 by dietary butylated hydroxyanisole. Carcinogenesis 21 1013-1016. (Pubitemid 30265148)
11. Kim HJ, Chae HZ, Kim YJ, Kim YH, Hwangs TS, Park EM & Park YM 2003 Preferential elevation of Prx I and Trx expression in lung cancer cells following hypoxia and in human lung cancer tissues. Cell Biology and Toxicology 19 285-298.
12. Kim YJ, Lee WS, Ip C, Chae HZ, Park EM & Park YM 2006 Prx1 suppresses radiation-induced c-Jun NH2-terminal kinase signaling in lung cancer cells through interaction with the glutathione S-transferase Pi/c-Jun NH2-terminal kinase complex. Cancer Research 66 7136-7142. (Pubitemid 44197691)
13. Kim JH, Bogner PN, Ramnath N, Park Y, Yu J & Park YM 2007 Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer. Clinical Cancer Research 13 3875-3882. (Pubitemid 47037594)
14. Kim J, Lowe T & Hoppe T 2008 Protein quality control gets muscle into shape. Trends in Cell Biology 18 264-272.
15. Lehtonen ST, Svensk AM, Soini Y, Paakko P, Hirvikoski P, Kang SW, Saily M & Kinnula VL 2004 Peroxiredoxins, a novel protein family in lung cancer. International Journal of Cancer 111 514-521. (Pubitemid 39045317)
16. Matsukawa J, Matsuzawa A, Takeda K & Ichijo H 2004 The ASK1-MAP kinase cascades in mammalian stress response. Journal of Biochemistry 136 261-265. (Pubitemid 39545783)
17. Mimnaugh EG, Xu W, Vos M, Yuan X, Isaacs JS, Bisht KS, Gius D & Neckers L 2004 Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity. Molecular Cancer Therapeutics 3 551-566. (Pubitemid 39193734)
18. Morita K, Saitoh M, Tobiume K, Matsuura H, Enomoto S, Nishitoh H & Ichijo H 2001 Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress. EMBO Journal 20 6028-6036. (Pubitemid 33049278)
19. Nencioni A, Hua F, Dillon CP, Yokoo R, Scheiermann C, Cardone MH, Barbieri E, Rocco I, Garuti A, Wesselborg S et al. 2005 Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis. Blood 105 3255-3262.
20. Neumann CA, Krause DS, Carman CV, Das S, Dubey DP, Abraham JL, Bronson RT, Fujiwara Y, Orkin SH & Van Etten RA 2003 Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 424 561-565. (Pubitemid 36975778)
21. Nishitoh H, Saitoh M, Mochida Y, Takeda K, Nakano H, Rothe M, Miyazono K & Ichijo H 1998 ASK1 is essential for JNK/SAPK activation by TRAF2. Molecular Cell 2 389-395. (Pubitemid 128379279)
22. Park JH, Kim YS, Lee HL, Shim JY, Lee KS, Oh YJ, Shin SS, Choi YH, Park KJ, Park RW et al. 2006 Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung. Respirology 11 269-275.
23. Podar K, Gouill SL, Zhang J, Opferman JT, Zorn E, Tai YT, Hideshima T, Amiot M, Chauhan D, Harousseau JL et al. 2008 A pivotal role for Mcl-1 in Bortezomib-induced apoptosis. Oncogene 27 721-731. (Pubitemid 351186317)
24. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K & Ichijo H 1998 Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO Journal 17 2596-2606. (Pubitemid 28221195)
25. Shi J, Tricot GJ, Garg TK, Malaviarachchi PA, Szmania SM, Kellum RE, Storrie B, Mulder A, Shaughnessy JD Jr, Barlogie B et al. 2008 Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell-mediated lysis of myeloma. Blood 111 1309-1317. (Pubitemid 351213417)
26. Song IS, Kim SU, Oh NS, Kim J, Yu DY, Huang SM, Kim JM, Lee DS & Kim NS 2009 Peroxiredoxin I contributes to TRAIL resistance through suppression of redox-sensitive caspase activation in human hepatoma cells. Carcinogenesis 30 1106-1114.
27. Tobiume K, Inage T, Takeda K, Enomoto S, Miyazono K & Ichijo H 1997 Molecular cloning and characterization of the mouse apoptosis signal-regulating kinase 1. Biochemical and Biophysical Research Communications 239 905-910. (Pubitemid 27504201)
28. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T & Ichijo H 2001 ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Reports 2 222-228. (Pubitemid 32273301)
29. Wang HQ, Du ZX, Zhang HY & Gao DX 2007 Different induction of GRP78 and CHOP as a predictor of sensitivity to proteasome inhibitors in thyroid cancer cells. Endocrinology 148 3258-3270.
30. Wang HQ, Liu HM, Zhang HY, Guan Y & Du ZX 2008 Transcriptional upregulation of BAG3 upon proteasome inhibition. Biochemical and Biophysical Research Communications 365 381-385. (Pubitemid 350137301)
31. Wijayanti N, Naidu S, Kietzmann T & Immenschuh S 2008 Inhibition of phorbol ester-dependent peroxiredoxin I gene activation by lipopolysaccharide via phosphorylation of RelA/p65 at serine 276 in monocytes. Free Radical Biology & Medicine 44 699-710.
32. Xin H, Xu X, Li L, Ning H, Rong Y, Shang Y, Wang Y, Fu XY & Chang Z 2005 CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation. Journal of Biological Chemistry 280 20842-20850. (Pubitemid 40776789)
33. Yanagawa T, Ishikawa T, Ishii T, Tabuchi K, Iwasa S, Bannai S, Omura K, Suzuki H & Yoshida H 1999 Peroxiredoxin I expression in human thyroid tumors. Cancer Letters 145 127-132. (Pubitemid 29459080)
34. Yanagawa T, Iwasa S, Ishii T, Tabuchi K, Yusa H, Onizawa K, Omura K, Harada H, Suzuki H & Yoshida H 2000 Peroxiredoxin I expression in oral cancer: a potential new tumor marker. Cancer Letters 156 27-35. (Pubitemid 30326764)
35. Yang W, Monroe J, Zhang Y, George D, Bremer E & Li H 2006 Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells. Cancer Letters 243 217-227. (Pubitemid 44485853)
36. Zaarur N, Gabai VL, Porco JA Jr, Calderwood S & Sherman MY 2006 Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors. Cancer Research 66 1783-1791. (Pubitemid 43259964)